Promotion of Access of Health Disparity Groups for Diabetes

这项研究的核心是为了更好地了解糖尿病风险因素与糖尿病管理之间的差距，因为少数民族人群患糖尿病、并发症和死亡的风险明显更高。糖尿病核心中心的具体目标是：(1)促进健康差距群体参与糖尿病诊断和预防的研究和临床计划，以及(2)与社区团体合作，以 制定创新战略，增加少数民族对糖尿病预防和治疗方案的参与。 糖尿病研究核心的重点将是加强少数族裔对哥伦比亚大学Naomi Berrie糖尿病中心正在进行的糖尿病研究和项目的参与。糖尿病核心中心将与社区核心的规划委员会合作，确定社区合作伙伴，参与有关糖尿病研究目标的讨论，并在各自的组织中制定计划，使更多的社区居民能够参与研究设计或实施。根据已经与学校开展的工作，核心建议继续优先开展儿童和青少年方面的工作。研究协调员将通过社区核心制定更好的战略，让学校、家长和青少年参与关于肥胖、运动和糖尿病风险的论坛/研讨会。在这种参与的基础上，希望不仅有更多的学校有兴趣参与正在进行的研究，而且他们还将与该中心合作开展糖尿病预防活动。通过这次参与，我们寻求让曼哈顿北部的西班牙裔和非裔美国人居民参与三项正在进行的主要研究：儿童和青少年中的2型糖尿病；雷米普利和罗格列酮药物治疗的糖尿病减少评估(DREAM)试验；以及糖尿病心血管疾病预防(ACCORD)试验。

This research core is aimed at better understanding the gap between diabetes risk factors and diabetes management among racial and ethnic minority populations, which are at markedly higher risk of incurring diabetes, of complications, and of mortality. The specific aims of the Diabetes Core are: (1) to promote participation of health disparity groups in research and clinical programs in diagnosis and prevention of diabetes, and (2) to collaborate with community groups to develop innovative strategies to increase participation of racial and ethnic minorities in diabetes prevention and treatment programs. The focus of the Diabetes Research Core will be on enhancing the participation of racial and ethnic minorities in the conduct of ongoing diabetes studies and programs at the Naomi Berrie Diabetes Center at Columbia University. Working with the Community Core's Planning Council, the Diabetes Core will identify community partners to participate in discussions about the objectives of diabetes studies and to develop programs at their own organizations to enable more community residents to participate in either study design or implementation. Based on the work already underway with the schools, the core proposes to continue to prioritize work with young children and adolescents. The study coordinator will work through the Community Core to develop enhanced strategies for engaging schools, parents and adolescents in forums/ workshops about obesity, exercise and diabetes risk. Growing out of this participation, it is hoped not only that more schools will be interested in participating in ongoing studies, but that they will also work with the center to develop diabetes prevention activities. Through this participation, we seek to engage the Hispanic and African-American residents of northern Manhattan in three ongoing major studies: Type 2 diabetes in children and adolescents; the Diabetes Reduction Assessment with Ramipril and Rosiglitizone Medication (DREAM) trial; and the Prevention of Cardiovascular Disease in Diabetes (ACCORD) trial.